148 related articles for article (PubMed ID: 16944359)
1. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
[TBL] [Abstract][Full Text] [Related]
2. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
[TBL] [Abstract][Full Text] [Related]
3. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo.
Bullard AJ; Govewalla P; Yellon DM
Basic Res Cardiol; 2005 Sep; 100(5):397-403. PubMed ID: 15944807
[TBL] [Abstract][Full Text] [Related]
5. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
[TBL] [Abstract][Full Text] [Related]
6. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
7. Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism.
Zhang KR; Liu HT; Zhang HF; Zhang QJ; Li QX; Yu QJ; Guo WY; Wang HC; Gao F
Apoptosis; 2007 Sep; 12(9):1579-88. PubMed ID: 17505785
[TBL] [Abstract][Full Text] [Related]
8. Aging mouse hearts are refractory to infarct size reduction with post-conditioning.
Przyklenk K; Maynard M; Darling CE; Whittaker P
J Am Coll Cardiol; 2008 Apr; 51(14):1393-8. PubMed ID: 18387442
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
10. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
[TBL] [Abstract][Full Text] [Related]
11. [Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation].
Miki T; Miura T; Tsuchida A; Nakano A; Hasegawa T; Fukuma T; Shimamoto K
J Cardiol; 2001 Feb; 37(2):112-3. PubMed ID: 11255694
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin enhances the therapy potency of autologous bone marrow stromal cells in a rat heart infarction model via phosphatidylinositol-3-kinase/Akt pathway].
Zhang DG; Zhang FM; Zhang YQ; Zhou F; Gao X; Li CF; Cao KJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):912-6. PubMed ID: 17217721
[TBL] [Abstract][Full Text] [Related]
14. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
[TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT, JNK, and ERK pathways are not crucial for the induction of cholesterol biosynthesis gene transcription in intestinal epithelial cells following treatment with the potato glycoalkaloid alpha-chaconine.
Mandimika T; Baykus H; Poortman J; Garza C; Kuiper H; Peijnenburg A
J Agric Food Chem; 2008 Sep; 56(18):8745-52. PubMed ID: 18729378
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein.
Bhuiyan MS; Takada Y; Shioda N; Moriguchi S; Kasahara J; Fukunaga K
Cardiovasc Ther; 2008; 26(1):10-23. PubMed ID: 18466417
[TBL] [Abstract][Full Text] [Related]
17. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.
Jin ZQ; Karliner JS; Vessey DA
Cardiovasc Res; 2008 Jul; 79(1):134-40. PubMed ID: 18334546
[TBL] [Abstract][Full Text] [Related]
19. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
